ETV2 upregulation marks the specification of early cardiomyocytes and endothelial cells during co-differentiation.
Xu CaoMaria MirceaGopala Krishna YakalaFrancijna E van den HilMarcella BresciaHailiang MeiChristine L MummeryStefan SemrauValeria V OrlovaPublished in: Stem cells (Dayton, Ohio) (2022)
The ability to differentiate human induced pluripotent stem cells (hiPSCs) efficiently into defined cardiac lineages, such as cardiomyocytes and cardiac endothelial cells, is crucial to study human heart development and model cardiovascular diseases in vitro. The mechanisms underlying the specification of these cell types during human development are not well-understood which limits fine-tuning and broader application of cardiac model systems. Here, we used the expression of ETV2, a master regulator of hematoendothelial specification in mice, to identify functionally distinct subpopulations during the co-differentiation of endothelial cells and cardiomyocytes from hiPSCs. Targeted analysis of single-cell RNA sequencing data revealed differential ETV2 dynamics in the two lineages. A newly created fluorescent reporter line allowed us to identify early lineage-predisposed states and show that a transient ETV2-high state initiates the specification of endothelial cells. We further demonstrated, unexpectedly, that functional cardiomyocytes can originate from progenitors expressing ETV2 at a low level. Our study thus sheds light on the in vitro differentiation dynamics of two important cardiac lineages.
Keyphrases
- endothelial cells
- high glucose
- single cell
- induced pluripotent stem cells
- acute lymphoblastic leukemia
- vascular endothelial growth factor
- left ventricular
- rna seq
- cell fate
- poor prognosis
- cardiovascular disease
- high throughput
- heart failure
- air pollution
- type diabetes
- atrial fibrillation
- coronary artery disease
- transcription factor
- drug delivery
- skeletal muscle
- brain injury
- cardiovascular risk factors
- machine learning
- metabolic syndrome
- cardiovascular events
- cell therapy
- bone marrow